Colfax Schedules Fourth Quarter and Fiscal Year 2021 Earnings Release and Conference Call

Rhea-AI Summary

Colfax Corporation (NYSE: CFX) announced that it will release its financial results for Q4 and fiscal year 2021 on February 22, 2022. The company will hold a conference call at 8:00 a.m. Eastern on the same day, accessible to the public via phone and webcast. Colfax is known for its orthopedic and fabrication technology products under the DJO and ESAB brands. Additionally, the company is proceeding with its planned separation into two independent firms, focusing on specialty medical technologies and fabrication technologies, anticipated to conclude by Q1 2022.

Positive

• Planned separation into two companies expected to unlock value.
• Strong focus on specialized sectors—medical technologies and fabrication technologies.

Negative

• None.

     

Wilmington DE, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it will issue a press release providing financial results for the fourth quarter and fiscal year 2021 on the morning of Tuesday, February 22, 2022. The Company will hold a conference call to discuss these results beginning at 8:00 a.m. Eastern on that day, which will be open to the public by calling +1-877-303-7908 (U.S. callers) and +1-678-373-0875 (International callers) and referencing the conference ID number 7466839 and through webcast via Colfax’s website www.colfaxcorp.com under the “Investors” section.

Colfax’s financial results press release and supplemental information referenced on the call, if any, for the fourth quarter and fiscal year 2021 will be available under the “Investors” section of Colfax’s website prior to the conference call. A link to a replay of the call will also be available on the Colfax website later that day.

About Colfax Corporation

Colfax Corporation (NYSE: CFX) is a leading diversified technology company that provides orthopedic and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. The Company uses its Colfax Business System, a comprehensive set of tools and processes, to create superior value for customers, stockholders and associates. In March of 2021, Colfax announced its intention to separate into two independent and public companies, which is targeted to be completed near the end of the first quarter of 2022, to accelerate strategic momentum and unlock additional value creation potential. Enovis Corporation will focus on specialty medical technologies and ESAB Corporation will focus on fabrication technologies. For more information about Colfax and our separation activities, please visit www.colfaxcorp.com.

Contact:
Mike Macek
Vice President, Finance
Colfax Corporation
+1-302-252-9129
investorrelations@colfaxcorp.com

FAQ

When will Colfax Corporation announce its Q4 and fiscal year 2021 financial results?

Colfax Corporation will announce its financial results on February 22, 2022.

What time is the Colfax conference call scheduled for?

The conference call is scheduled for 8:00 a.m. Eastern on February 22, 2022.

How can investors access the Colfax financial results conference call?

Investors can access the call by phone or via a webcast on Colfax’s website.

What are the two independent companies resulting from Colfax's planned separation?

The two companies will be Enovis Corporation, focusing on specialty medical technologies, and ESAB Corporation, focusing on fabrication technologies.